X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (4947) 4947
Publication (477) 477
Book Review (52) 52
Book Chapter (27) 27
Dissertation (18) 18
Conference Proceeding (12) 12
Government Document (7) 7
Magazine Article (2) 2
Data Set (1) 1
Paper (1) 1
Web Resource (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (3428) 3428
her2 (3230) 3230
index medicus (2885) 2885
female (2747) 2747
oncology (2536) 2536
breast cancer (2423) 2423
trastuzumab (1679) 1679
cancer (1461) 1461
immunohistochemistry (1384) 1384
middle aged (1381) 1381
receptor, erbb-2 - metabolism (1357) 1357
aged (1181) 1181
breast neoplasms - pathology (1139) 1139
receptor, erbb-2 - genetics (1136) 1136
adult (1105) 1105
gene amplification (1099) 1099
chemotherapy (983) 983
breast neoplasms - metabolism (944) 944
breast neoplasms - genetics (940) 940
prognosis (921) 921
expression (902) 902
breast neoplasms - drug therapy (890) 890
pathology (889) 889
amplification (776) 776
skin and connective tissue diseases (773) 773
epidermal growth factor (719) 719
in-situ hybridization (692) 692
therapy (691) 691
metastasis (656) 656
tumors (652) 652
breast-cancer (648) 648
male (629) 629
analysis (621) 621
research (611) 611
aged, 80 and over (600) 600
care and treatment (596) 596
carcinoma (588) 588
survival (580) 580
medicine & public health (579) 579
animals (572) 572
antineoplastic agents - therapeutic use (542) 542
cell line, tumor (538) 538
in situ hybridization, fluorescence (538) 538
monoclonal-antibody (499) 499
genetic aspects (497) 497
overexpression (485) 485
gene expression (447) 447
cell biology (445) 445
her2/neu (435) 435
growth-factor receptor (427) 427
neoplasms (424) 424
adjuvant chemotherapy (420) 420
erbb-2 protein (413) 413
treatment outcome (398) 398
egfr (391) 391
gene expression regulation, neoplastic (391) 391
receptor, erbb-2 - analysis (388) 388
antibodies, monoclonal, humanized (382) 382
neoplasm staging (373) 373
gastric cancer (372) 372
her-2/neu (366) 366
receptor (363) 363
health aspects (361) 361
retrospective studies (358) 358
proteins (356) 356
biomarkers, tumor - metabolism (355) 355
mice (342) 342
cancer therapies (337) 337
receptor, erbb-2 - antagonists & inhibitors (336) 336
cancer research (330) 330
biomarkers, tumor - genetics (322) 322
fish (317) 317
antineoplastic combined chemotherapy protocols - therapeutic use (314) 314
medical prognosis (308) 308
mutation (306) 306
article (305) 305
receptor, erbb-2 - biosynthesis (302) 302
biomarkers, tumor - analysis (298) 298
kinases (297) 297
breast neoplasms - diagnosis (291) 291
genes, erbb-2 (291) 291
disease-free survival (289) 289
lapatinib (289) 289
erbb2 (281) 281
development and progression (276) 276
antibodies, monoclonal - therapeutic use (275) 275
resistance (271) 271
biochemistry & molecular biology (268) 268
oncogene (267) 267
fluorescence in situ hybridization (265) 265
protein expression (265) 265
surgery (265) 265
hematology, oncology and palliative medicine (256) 256
breast neoplasms - mortality (255) 255
stomach cancer (255) 255
growth (253) 253
stomach neoplasms - pathology (249) 249
estrogen-receptor (248) 248
antineoplastic agents - pharmacology (246) 246
signal transduction (246) 246
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (4860) 4860
French (59) 59
Japanese (38) 38
German (26) 26
Korean (11) 11
Spanish (9) 9
Chinese (8) 8
Polish (5) 5
Italian (1) 1
Norwegian (1) 1
Persian (1) 1
Portuguese (1) 1
Russian (1) 1
Slovenian (1) 1
Turkish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Cancer Discovery, ISSN 2159-8274, 10/2012, Volume 2, Issue 10, pp. 922 - 933
EGFR-mutant lung cancers eventually become resistant to treatment with EGFR tyrosine kinase inhibitors (TKIs). The combination of EGFR-TKI afatinib and... 
lung cancer | EGFR tyrosine kinase inhibitors | afatinib | EGFR mutations | erlotinib | HER2 amplification | cetuximab | EGFR T790M | acquired resistance
Journal Article
Journal Article
Cancer Discovery, ISSN 2159-8274, 08/2016, Volume 6, Issue 8, pp. 838 - 851
Journal Article
Histopathology, ISSN 0309-0167, 01/2019, Volume 74, Issue 2, pp. 300 - 310
Journal Article
BMC CANCER, ISSN 1471-2407, 01/2019, Volume 19, Issue 1, pp. 38 - 9
BackgroundHER2 (ERBB2 or HER2/neu) is a tyrosine-kinase increasing cell proliferation. Overexpression/amplification of HER2 is correlated with worse prognosis... 
Immunohistochemistry | Prognosis | GASTROESOPHAGEAL JUNCTION | TRASTUZUMAB | AMERICAN-PATHOLOGISTS | neu (ERBB2) | SOCIETY | GUIDELINE | Fluorescence-in-situ-hybridization (FISH) | BREAST-CANCER | HETEROGENEITY | ONCOLOGY | CHEMORADIATION | Esophageal adenocarcinoma (EAC) | Tissue microarray (TMA) | HER2 | BIOPSIES | Analysis | Genetic aspects | Research | Gene expression | Esophageal cancer | HER2/neu (ERBB2)
Journal Article
Journal Article